Results 91 to 100 of about 20,077 (158)

Carbapenem-Resistant Enterobacteriaceae Bloodstream Infections in Neonates: Clinical Characteristics and Antimicrobial Therapy. [PDF]

Can J Infect Dis Med Microbiol
Liu Z, Xu X, Li S, Li M, Jiao J, Guo Y, Ma L.   +6 more
europepmc   +1 more source

Antimicrobial Activity of Aztreonam-Avibactam and Other β-Lactamase Inhibitor Combinations Tested Against Enterobacterales Isolates from Pediatric Patients from United States Medical Centers (2019-2023). [PDF]

Antibiotics (Basel)
Sader HS, Winkler ML, Papp-Wallace KM, Mendes RE, Castanheira M.   +4 more
europepmc   +1 more source

Correction: Molecular resistance mechanisms to newly approved antibiotics (2017-2025) in WHO priority pathogens. [PDF]

Front Microbiol
Frontiers Production Office.
europepmc   +1 more source

Antimicrobial susceptibility of Enterobacterales causing infection in the elderly: focus on aztreonam-avibactam and recently approved β-lactamase inhibitor combinations. [PDF]

JAC Antimicrob Resist
Sader HS, Mendes RE, Kimbrough JH, Papp-Wallace KM, Winkler ML, Castanheira M.   +5 more
europepmc   +1 more source

Influence of PER-7 on cefiderocol susceptibility in clinical isolates of <i>Acinetobacter baumannii</i> producing OXA-23 or OXA-72 carbapenemases. [PDF]

JAC Antimicrob Resist
Turowski P, Cremanns M, Eisfeld J, Gatermann S, Pfennigwerth N.   +4 more
europepmc   +1 more source

Antimicrobial Susceptibility of Ceftazidime-Avibactam in Clinical Isolates of Carbapenemase-Producing Enterobacterales. [PDF]

Cureus
Jain S, Vyas A, Chaturvedi P.
europepmc   +1 more source

Antibiotics for the Treatment of Patients with Metallo-β-Lactamase (MBL)-Producing Gram-Negative Bacterial Infections. [PDF]

Antibiotics (Basel)
Falagas ME, Kontogiannis DS, Ragias D, Kakoullis SA.   +3 more
europepmc   +1 more source